| Guidelines | Composition of IEC | Meetings | Studies Concluded | Ongoing StudiesAcademic Presentations |

Ongoing Studies

S.No

Name of Study

National / International

Principal Investigator

1

FG-463-210; A Randomized, comparative, Double-Blinded study of Micafungin (FK463) versus Liposomal Amphotericin B (AMBISOME)

International

Dr N Krishna Reddy

2

A randomized double blind, double dummy parallel group, multinational, clinical study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in patients with acute ST-segment elevation myocardial infarction receiving fibrinolytic therapy" EXTRACT-TIMI-25 Study

International

Dr N Krishna Reddy

3

Clinical trial of Reviparin and metabolic modulation in acute myocardial infarction treatment evaluation” The CREATE Study.

International

Dr B K S Sastry

4

A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the treatment of Children, Aged 1-16 Years, With Pulmonary Arterial Hypertension.

International

Dr B K S Sastry

5

Clinical utility of Amlodipine/Atorvastatin to improve concomitant cardiovascular risk factors of Hypertension and Dyslipidemia (GEMINI-AALA) .

International

Dr B K S Sastry

6

Action in Diabetes and Vascular disease preterax and Diamicron MR Controlled Evaluation” - ADVANCE Study.

>> Detail in next page

International

Dr P Krishnam Raju

7

Hyperglycemia and its effect after Acute Myocardial Infarction on Cardiovascular Outcomes in Patients with Type-2 diabetes (HEART-2D).

International

Dr Bipin K Sethi

8

A multi-center, International, Randomized, 2x2 factorial design study to evaluate the effects of LANTUS® (Insulin Glargine) versus standard care, and of  OMEGA-3 fatty acids versus placebo, in reducing Cardiovascular Morbidity and Mortality in high risk people with Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or early type 2 Diabetes Mellitus: The origin trial (outcome reduction with Initial Glargine Intervention)” ORIGIN Study.

International

Dr Bipin K Sethi

9

Protocol for a mortality surveillance system that will determine the leading causes of death in rural Andhra Pradesh.

International

Dr P Krishnam Raju

10

Prospective randomized placebo controlled trial  to assess the role of  GP IIb / IIIa blockade by Intergrilin by patients with Troponin increase and non persistent ST segment elevation acute coronary syndrome.

National

Dr Sunil K Kapoor

11

A Multicenter, Long Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects who have Completed Study A 1481831.” Protocol No: A1481856.

International

Dr B K S Sastry

12

Andhra Pradesh Rural Health Survey. 

>> Detail in next page

International

Dr P Krishnam Raju

13

A two-year, multinational, multi-centre, 2:1 randomized, parallel-group, open-labeled trial comparing the efficacy and safety of insuling  detemir and NPH insulin in subjects with type 1 diabetes on a basal-bolus regimen with insulin as part as mealtime insulin” Trial ID: NN304-1595.

International

Dr Bipin K Sethi

14 The Surgical Treatment for Ischaemic Heart Failure (STICH ) Trial

>> Detail in next page

International Dr P Krishnam Raju

Next Page >>

| Guidelines | Composition of IEC | Meetings | Studies Concluded | Ongoing StudiesAcademic Presentations |


Copyright © 2004, C A R E  Foundation - All rights reserved.